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Epstein-Barr viral (EBV) DNA has been regularly 
demonstrated in biopsy material from two different 
human tumors: Burkitt's lymphoma and naso-
pharyngeal carcinoma (zur Hausen et al. 1970, 
1974b; Nonoyama and Pagano 1973; Wolf et al. 
1973). Patients carrying either of these tumors 
reveal elevated antibody titers against EB viral 
capsid antigens (VCA) and in a high percentage also 
against E B V early antigens (EA) (Henle et al. 
1970a,b). 
In Burkitt's lymphoma cells, EBV-specific mem-
brane antigens (Gunven et al. 1970) as well as 
EB-associated nuclear antigens (EBNA) have been 
demonstrated (Reedman and Klein 1973; Reedman 
et al. 1974). The transforming potential of E B V for 
lymphatic cells has been shown in vitro (Henle et al. 
1967; Pope et al. 1968). Recently the susceptibility 
of immunoglobulin-synthesizing lymphocytes has 
been convincingly demonstrated (Klein et al., un-
publ.; Schneider and zur Hausen 1975). It appears 
that type T lymphocytes lack receptors for E B V 
absorption (Jondal and Klein 1973). 
A variety of non-Burkitt type B lymphomas do not 
contain EBV-specific nucleic acids and antigens 
(Lindahl et al. 1974), despite the presence of E B V 
antibodies and the apparent persistence of the virus 
in cells of the peripheral blood. This provides further 
indirect evidence for the unique role of E B V in 
Burkitt's lymphoma. 
Nasopharyngeal carcinomas contain, in contrast 
to Burkitt's lymphoma, a mixed cell population. 
Islands of nonlymphatic epithelial tumor cells are 
infiltrated to a varying extent by lymphocytes 
(Shanmugaratnam 1972). The degree of lymphatic 
infiltration has even been used to subclassify this 
tumor, which was originally named "lymphoepithe-
lioma." The rather well known "lymphotropism" 
of E B V suggested to some investigators that the 
viral D N A demonstrated in these tumors by nucleic 
acid hybridizations should be located within the 
infiltrating lymphocytes (McAllister 1973). Thus 
the nonlymphoid tumor cells would not contain 
virus-specific products. 
Previous data from our laboratory were at vari-
ance with this interpretation (Wolf et al. 1973). 
They revealed the presence of viral DNA within 
epithelial cells of the two tumors examined by in 
situ hybridizations and anticomplementary im-
munofluorescence. The following is an extension of 
these studies which establishes further the presence 
of EB viral DNA within the tumor cells of naso-
pharyngeal carcinomas. 
In addition, the recent induction of lympho-
proliferative disease by E B V in marmosets (Shope 
et al. 1973) and an owl monkey (Epstein et al. 1973) 
stimulated us to similar experiments. It was our 
intention to infect primates with virus isolates from 
different virus-producing lymphoblastoid lines and 
to demonstrate virus-specific nucleic acids within 
the tumor material of such animals. The following 
report summarizes the results. 
M A T E R I A L A N D M E T H O D S 
Cells. P3HR-1 cells of Burkitt's tumor origin (Hinuma 
et al. 1967) and Kaplan cells derived from a patient with 
infectious mononucleosis (Diehl et al. 1968) were both 
obtained from Werner Henle, Philadelphia. They were 
kept in medium RPMI 1640 supplemented with 10% fetal 
calf serum. 
Virus preparations. Methods of viral purification and 
extraction of viral DNA have been reported before (Schulte-
Holthausen and zur Hausen 1970; zur Hausen et al. 1970). 
Methods of filter hybridizations with virus-specific com-
plementary RNA (cRNA) and of in situ hybridizations 
were also reported elsewhere (zur Hausen et al. 1974a). 
Indirect immunofluorescence to determine EBV-specific 
antibodies against viral capsid antigens and the early 
antigen complex was performed according to Henle et al. 
(1971). 
Collection of tumor specimens and DNA extraction. All 
tumor materials were obtained through the courtesy of 
G. Klein, Stockholm and S. Singh, Nairobi. They were 
shipped to Erlangen in ice water immediately after surgi-
cal removal. The method of D N A extraction has been re-
ported (zur Hausen et al. 1970). 
Labeling of EBV DNA. The method of Dumas et al. 
(1971) and Nonoyama and Pagano (1973) was followed 
with minor modifications. E B V DNA (1.5 fxg) was incubated 
for 15 min at 37°C in a volume of 0.5 ml containing 0.05 
fig pancreatic DNase, 10 mM MgCl 1 m M mercaptoethanol, 
0.05 M Tris, 10 m M CaCl 2 and 1 m M Na citrate. The reac-
tion was stopped by incubating the mixture for 10 min 
at 70°C. After chilling the solution, 10/xl DNA polymerase 
I (containing 1.5 units of the enzyme in 50% glycerol) was 
added and the total volume was increased to 0.75 ml, now 
containing 100 nmoles each of dATP and dGTP, 10 nmoles 
each of [ 3H]dTTP (spec. act. 45 Ci/mmole) and [ a H]dCTP 
(spec. act. 13.3 Ci/mmole), 10 mM K 2 H P 0 4 , 0.05 M Tris, 
75 m M MgCl 2 , 0.73 m M mercaptoethanol, 6.7 mM NaCl and 
0.7 mM Na citrate. The pH was adjusted to 7.4. After 
further incubation at 17°C for 2 hr followed by phenol 
extraction, the material was chromatographed on a 
Sephadex G50 column. Approximately 0.43% of the radio-
activity was found to be acid insoluble. The specific ac-
tivity of the DNA was calculated to amount to 1.26 x 106 
cpm//ug. 
Reassociation kinetics of hybridization. The procedure 
of Britten and Kohne (1971) and of Gelb et al. (1971) was 
followed with minor modifications. One mg cellular D N A 
was dissolved in 0.5 ml containing 1 M NaCl, 0.5 M Tris 
pH 7.4, 0.01 M E D T A , 0.05% sarcosyl and 10 ng radio-
active E B V DNA and sonified for 3 x 10 sec at 70 w by 
using the Branson microtip sonifier. Fifty fx\ samples 
were brought into capillaries and then again sonified for 
10 min at 100 w with the macrotip of the Branson sonifier. 
The capillaries were then incubated 10 min at 120°C in 
diethyleneglycol. Since additional experiments revealed 
that E B V D N A melted under these conditions at a T m of 
97°C, incubation was continued at a temperature of 73°C 
(Wetmur and Davidson 1968). 
After varying periods of incubation, the samples were 
chromatographed on hydroxylapatite columns at 60°C by 
adding consecutively 4 X 0.5 ml and 1 X 1 ml of 0.14 M 
phosphate buffer containing 0.4% sodium dodecyl sulfate 
(SDS). Double-stranded D N A was eluted with 3 x 0.5 ml 
0.4 M phosphate buffer. 
R E S U L T S A N D D I S C U S S I O N 
EBV DNA in Nasopharyngeal Carcinomas 
DNA from biopsies of 34 nasopharyngeal carci-
nomas was hybridized with E B V cRNA. Eleven of 
these tumors annealed to a higher extent than 
DNA derived from Raji cells, a non-virus-producing 
lymphoblastoid line which was shown in previous 
experiments to harbor approximately 50 genome 
equivalents of E B V DNA (Nonoyama and Pagano 
1971; zur Hausen et al. 1972). Only three tumor 
materials were entirely negative in this test. A 
careful histological reexamination of remaining 
material from these biopsies did not reveal any 
tumorous tissue in two of these, whereas the third 
one represented an adenocarcinoma. 
The careful histological analysis of the tumors 
showed that all highly hybridizing tumors were of 
predominantly epithelial morphology, whereas 
lymphatic cells represented a majority in most of 
the remaining biopsies. This was in agreement 
with our previous findings (Wolf et al. 1973) sug-
gesting the presence of E B V D N A within epithelial 
tumor cells, and was further substantiated by in 
situ hybridizations of cytological preparations. 
For this purpose, tumors were selected which 
contained almost equal amounts of epithelial and 
lymphatic cells. A nonhybridizing tumor served as 
control. Freeze sections of these materials were 
treated with RNase, alkali-denatured, incubated 
with E B V cRNA, again treated with RNase and 
then exposed to autoradiography (Wolf et al. 
unpubl.). The result is shown in Figure 1. Regions 
of large, pale nuclei are obviously preferentially 
labeled. Such regions correspond to nonlymphoid 
cells in the nondenatured sections. No labeling was 
observed within the control material. These results 
further confirm and clarify the specific association 
of E B V with epithelial nasopharyngeal carcinoma 
cells. The labeling of nonlymphoid cells appears to 
be confined to the nuclear region, although the 
denaturation procedure affects the morphology of 
the cells. These data do not, of course, preclude that 
some of the lymphoid cells in the nasopharyngeal 
tumors also carry viral DNA, particularly since 
EBV-synthesizing lymphoblastoid cell lines have 
been established from some of these tumors. Addi-
tional experiments reveal, however, that the EBV 
DNA content of the lymphoid fraction in naso-
pharyngeal carcinomas must be very small and 
therefore escapes detection in many instances: 
Recently Claude Desgranges (International Agency 
for Research on Cancer, Lyon) fractionated cells 
from nasopharyngeal carcinomas in Ficoll gradients 
and separated lymphocytes from the remaining 
tumor cells. From three such tumors, sufficient DNA 
was obtained to test separately the DNA of the 
lymphocytic and epithelial fractions. Hybridization 
of these samples with E B V cRNA was carried out 
in our laboratory. The data revealed a convincing 
picture: no significant hybridization was found 
within the lymphocyte DNA, whereas all three 
epithelial preparations annealed clearly above the 
range of Raji cell DNA. 
Furthermore, hybridization of DNA from leuko-
cytes of the peripheral blood of patients with naso-
pharyngeal carcinomas with E B V cRNA did not 
result in significant annealing. Thus it appears to 
be firmly established that nasopharyngeal carci-
noma represents the second human malignancy, in 
addition to Burkitt's lymphoma, in which viral 
DNA can be regularly demonstrated within the 
tumor cells. Besides the infection of type B lympho-
cytes (Jondal and Klein 1973), E B V obviously in-
fects specific additional cells of apparently epithelial 
morphology. 
EBV Induction of a Malignant Lymphoma in a 
Cottontop Marmoset 
Shope et al. (1973) and Epstein et al. (1973) in-
duced tumors in marmosets or an owl monkey by 
injecting them with E B V derived from a marmoset 
line transformed in vitro by E B V (Miller et al. 
1972) or with virus obtained from a Burkitt's 
lymphoma line. It was our intention to test whether 
or not E B V directly derived from Kaplan cells, a 
lymphoblastoid line from a patient with infectious 
mononucleosis (Diehl et al. 1968), was also able to 
Figure 1. In s i tu hybridizat ion of E B V c R N A wi th freeze sections of a nasopharyngeal carcinoma. Hybr id izat ion was per-
formed w i t h 50,000 cpm of E B V c R N A i n a volume of 50 fx\. Note the grains on large, pale nuclei which correspond to non-
lymphoid cells i n nondenatured sections. 
i n d u c e t u m o r s i n v i v o . I n t h e e v e n t of t u m o r de-
v e l o p m e n t , we w a n t e d to test t h e b i opsy m a t e r i a l 
for t h e presence of E B V genomes . 
E B V w a s c o n c e n t r a t e d f r o m t h e s u p e r n a t a n t s of 
K a p l a n a n d P3HR-1 c e l l s . P a r t o f e a c h p r e p a r a t i o n 
w a s p r e i n c u b a t e d w i t h h u m a n s e r u m c o n t a i n i n g 
h i g h t i t e r s a g a i n s t E B V - s p e c i f i c a n t i g e n s . T h e 
r e m a i n i n g p a r t w a s s i m i l a r l y t r e a t e d w i t h h u m a n 
s e r u m d e v o i d o f d e t e c t a b l e E B V a n t i b o d y a c t i v i t y . 
T w o g r o u p s o f t h r e e co t tontop m a r m o s e t s e a c h 
r e c e i v e d e i t h e r t h e n o n - n e u t r a l i z e d K a p l a n con -
c e n t r a t e or t h e P3HR-1 p r e p a r a t i o n . S i m i l a r l y , two 
g r o u p s of t w o cot tontop m a r m o s e t s o b t a i n e d t h e 
n e u t r a l i z e d p r e p a r a t i o n s o f t h e r e s p e c t i v e v i r u s 
i so la tes . T h e v i r u s w a s in j e c ted i n t o t h e M . masseter. 
T h e a n i m a l s w e r e b l e d w e e k l y a n d e x a m i n e d for t h e 
d e v e l o p m e n t of E B V a n t i b o d i e s by i n d i r e c t i m m u n o -
fluorescence. 
S e v e n w e e k s a f t e r i n o c u l a t i o n , one o f t h e a n i m a l s 
w h i c h r e c e i v e d the n o n - n e u t r a l i z e d K a p l a n v i r u s 
deve loped s y m p t o m s of l y m p h o p r o l i f e r a t i v e d isease . 
I t w a s sac r i f i c ed 2 w e e k s l a t e r a n d a u t o p s i e d . A 
s o l i d t u m o r w a s f o u n d i n t h e s u b m a n d i b u l a r r e g i o n . 
I n a d d i t i o n , r e g i o n a l l y m p h nodes a n d s p l e e n r e -
v e a l e d h y p e r p l a s i a . 
H i s t o l o g i c a l e x a m i n a t i o n o f t h e t u m o r a n d 
s e r v e r a l o r g a n s o f t h e d i s e a s e d a n i m a l w a s per -
f o r m e d by D r . B e c k e r o f t h e D e p a r t m e n t of P a t h o l -
ogy , U n i v e r s i t y o f E r l a n g e n . T h e t u m o r m a t e r i a l 
( F i g . 2) e x h i b i t e d c h a r a c t e r i s t i c s o f a l y m p h o s a r c o m a 
w i t h n u m e r o u s n e c r o t i c foci . L y m p h nodes a n d 
s p l e e n s h o w e d some h y p e r p l a s i a b u t no t y p i c a l foci 
o f t u m o r o u s t i s s u e . S o m e l y m p h o c y t i c i n f i l t r a t i o n s 
w e r e r e c o g n i z a b l e w i t h i n t h e l i v e r m a t e r i a l . 
D N A f r o m t u m o r , s p l e e n , t h y m u s a n d l y m p h 
nodes w a s e x t r a c t e d a n d sub jec ted to E B V c R N A 
h y b r i d i z a t i o n s . W e f a i l e d to detect s i g n i f i c a n t a n -
n e a l i n g w i t h a n y o f these p r e p a r a t i o n s , p r o b a b l y 
due to t h e i n s e n s i t i v e a s s a y s ince p r e v i o u s r e c o n -
s t r u c t i o n tests h a d s h o w n t h a t t h i s E B V c R N A 
c o u l d not detect less t h a n t h r e e g e n o m e e q u i v a l e n t s 
per c e l l . I n o r d e r to i n c r e a s e t h e s e n s i t i v i t y of t h e 
assay , E B V D N A w a s l a b e l e d i n v i t r o a n d u s e d i n 
C 0 t h y b r i d i z a t i o n s w i t h t h e s a m e m a t e r i a l . T h e 
r e s u l t i s s h o w n i n F i g u r e 3. T h e i n p u t o f l a b e l e d 
v i r a l D N A u s e d i n t h i s tes t w i t h 2 m g o f c e l l u l a r 
D N A c o r r e s p o n d e d to 0.3 g e n o m e e q u i v a l e n t per 
c e l l . T h e a r t i f i c i a l a d m i x t u r e of 40 n g / m l o f E B V 
D N A s h o u l d c o r r e s p o n d to 1.08 g e n o m e e q u i v a l e n t s 
per c e l l , t h e 200 / x g / m l o f R a j i D N A to 5 g e n o m e 
e q u i v a l e n t s p e r c e l l . T h e f i g u r e s h o w s t h a t D N A 
d e r i v e d f r o m t h e t u m o r m a t e r i a l c o n t a i n e d s l i g h t l y 
m o r e t h a n one g e n o m e e q u i v a l e n t o f E B V D N A . 
Figure 2. Histology of the marmoset tumor induced by 
E B V derived from K a p l a n cells. Note the relative scarcity 
of tumor cells and the extended necrotic areas. 
Figure 3. C„t analysis of i n vitro-
labeled E B V D N A i n the presence of 
D N A derived from tumor and spleen 
of the tumor-bearing marmoset. A d d i -
t ional controls are indicated in the 
figure. 
Approximately 0.5 genome equivalent was found 
in the spleen DNA, whereas the DNA mixture 
from the thymus and unaffected lymph nodes did 
not enhance the reassociation reaction. 
In view of the relative scarcity of tumor cells 
within the tumor material, the actual concentra-
tion of viral D N A should be 4-5 times higher than 
calculated from the reassociation assay. In situ 
hybridizations performed on freeze sections of the 
tumor material failed to reveal significant cluster-
ing of grains. This is not surprising since this 
method represents a rather insensitive assay. It 
should exclude, however, viral particle synthesis 
in a few permissive cells as a reason for the observed 
amount of EBV-specific DNA. 
Lymphoblastoid cell lines were obtained from the 
tumor as well as from spleen material. Approxi-
mately 3% of these cells synthesize spontaneously 
EB viral capsid antigens as observed by immuno-
fluorescence. Typical herpesvirus particles were 
also found by electron microscopy, and the hy-
bridization rate with E B V cRNA was in the range 
of the virus-producing P3HR-1 line. Recently, trans-
formation of human umbilical cord lymphocytes 
was achieved with cell-free virus obtained from 
these lines. 
None of the nine additional cottontop marmosets 
inoculated either with non-neutralized or neu-
tralized Kaplan or P3HR-1 virus have developed 
tumors up to now. Except for the tumor-bearing 
marmoset, no rise in antibodies against E B V 
antigens was observed in any of the other animals. 
Even the tumor-carrying marmoset revealed a 
rather low titer against EB viral capsid antigens. 
Our failure to detect significant levels of E B V 
antibodies could be due to the use of FITC-coupled, 
anti-human y-globulin, since we had no access to 
anti-cottontop marmoset y-globulin. 
C O N C L U S I O N 
Our results show that E B V DNA can be regularly 
demonstrated in nonlymphoid epithelial naso-
pharyngeal carcinoma cells. Therefore nasopharyn-
geal carcinoma represents the second human 
malignancy, in addition to Burkitt's lymphoma, 
which contains the DNA of a transforming and 
oncogenic virus within the tumor cells. 
It was also shown that E B V derived from a patient 
with infectious mononucleosis induced a lympho-
sarcoma in a cottontop marmoset, that viral DNA 
was found in the tumor material, and that virus-
specific antigens as well as typical herpesvirus 
particles were present in lymphoblastoid cells ob-
tained from the tumor material and kept in tissue 
culture. 
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